OUTLOOK THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
OUTLOOK THERAPEUTICS, INC. (OTLK) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price of $1.77 per share as of 2021-06-30, per its 10-Q filed 2021-08-13.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice · last filed 2021-08-13
- 2021-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $1.77.
- 2021-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $1.93.
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $2.22.
- 2020-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $2.64.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2021-06-30 | $1.77 10-Q · filed 2021-08-13 |
| 2021-03-31 | $1.93 10-Q · filed 2021-05-14 |
| 2020-12-31 | $2.22 10-Q · filed 2021-02-16 |
| 2020-09-30 | $2.64 10-K · filed 2020-12-23 |
| 2020-06-30 | $3.34 10-Q · filed 2020-08-14 |
| 2020-03-31 | $4.03 10-Q · filed 2020-05-15 |
| 2019-12-31 | $4.63 10-Q · filed 2020-02-14 |
| 2019-09-30 | $7.19 10-K · filed 2019-12-19 |
| 2019-06-30 | $7.21 10-Q · filed 2019-08-14 |
| 2019-03-31 | $7.22 10-Q · filed 2019-05-15 |
| 2018-12-31 | $0.90 10-Q · filed 2019-02-14 |
| 2018-09-30 | $1.32 10-K · filed 2018-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |